On June 10, 2025, FDA Commissioner Martin A. Makary and Chief Medical and Science Officer Vinay Prasad published an article in the Journal of the American Medical Association titled, “Priorities for a New FDA.”1 The article...more
6/25/2025
/ Artificial Intelligence ,
Biosimilars ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Healthcare Reform ,
New Regulations ,
Popular ,
Prescription Drugs ,
Public Health ,
Regulatory Reform ,
Regulatory Requirements
This latest edition features articles on succeeding in the current life sciences funding market, strategic and legal considerations in digital health combinations, the corporate practice of medicine and guidance for...more
On March 5, 2025, the U.S. District Court for the Northern District of Texas denied the Outsourcing Facilities Association’s motion for a preliminary injunction to prevent the U.S. Food and Drug Administration (FDA) from...more